日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Questions and answers

What we know about the Omicron variant so far

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2021-11-30 18:15
Share
Share - WeChat
A medical worker prepares a dose of COVID-19 vaccine at a vaccination site in Pingxiang city, South China's Guangxi Zhuang autonomous region, Nov 16, 2021. [Xinhua/Cao Yiming]

Answers to commonly-asked questions about the Omicron variant of COVID-19.

Q: Where and when was Omicron first detected, and how far has it spread?

The B.1.1.529 variant was first identified in South Africa on Nov 9 and became the dominant strain in circulation in the Gauteng province of South Africa within two weeks. On Nov 26, the World Health Organization designated it the fifth variant of concern (VOC) and named it Omicron after the Greek letter. The virus did not necessarily originate in South Africa.

As of Nov 28, countries and regions including South Africa, Israel, Belgium, Italy, the United Kingdom, Austria and the Hong Kong Special Administrative Region, have reported cases of the new strain. No cases have been reported elsewhere in China as yet.

Q: How has it evolved?

Genome sequencing of the new variant shows that the number of mutations it carries are significantly higher than known strains in the past two years. These mutations are concentrated on the virus's spike protein.

Three scenarios likely explain its emergence:

1. The virus accumulated a large number of mutations through a persistent infection in an immunocompromised patient and spread as a new strain through a chance event;

2. The virus infected an animal group and as a result, evolved at a faster mutation rate. It then spilled over into the human population;

3. The new strain had already been circulating in places without sufficient monitoring systems for a long time, and earlier generations of the strain have been missed.

Q: Is it more transmissible?

There is no systematic data on the new strain's transmissibility, pathogenicity or its ability to evade immunity. But it contains key mutations observed in four other variants of concern — Alpha, Beta, Gamma and Delta — as well as mutations associated with the enhanced ability to bind to human cells and multiply.

Epidemiological studies and monitoring data points to a spike in Omicron infections in South Africa that threatens to replace the dominant Delta strain. More research is needed to determine contagiousness.

Q: What is the new strain's impact on vaccines and antibody treatment?

Research shows that three mutations on the virus's spike protein — K417N, E484A and N501Y — are linked to a stronger ability to evade immunity. Omicron carries all three, as well as other mutations that will likely diminish protection provided by antibody drugs.

More research is needed to determine its effect on existing vaccines.

Q: How about its impact on nucleic acid testing kits?

Genome sequencing analysis shows that the mutations will not affect the sensitivity and specificity of mainstream nucleic acid tests in China. Some laboratories in South Africa reported that testing kits being used there likely cannot detect the new strain effectively.

Q: What measures have been taken?

A number of countries and regions, including the United States, the United Kingdom, the European Union, Russia, Israel, the Hong Kong Special Administrative Region and Taiwan have restricted travel from South Africa.

Q: How is China responding?

China's strategy of preventing imported cases and swiftly dealing with local resurgences remains effective against the Omicron strain. The Chinese Center for Disease Control and Prevention has established testing methods for the new strain and will continuously sequence genomes of imported cases to catch possible infections in a timely manner.

Q: What can the public do to protect themselves against the new strain?

Wearing masks remains the most effective way to stem the spread of the virus, including the Omicron variant. It is recommended that all people, including the fully vaccinated and those receiving a booster shot, wear masks in indoor spaces and on public transportation. Regular hand washing and good ventilation are also important.

Given the limited understanding so far of the new strain and risk of infections in China, the public is recommended to avoid traveling to high-risk areas overseas and to step up personal protection during trips.

Source: National Health Commission

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 密桃成人av| 五月婷婷视频在线观看 | 麻豆欧美 | 日本国产高清 | 一区二区三区黄 | 日韩激情一区二区 | 国产精品一区一区三区 | 国产永久在线 | 欧美日韩亚洲在线观看 | 麻豆精品国产传媒 | 欧美一区亚洲一区 | 先锋成人资源 | 91综合视频 | 人人色网 | 亚洲激情综合 | 一区视频免费观看 | 免费91网站 | 久久久福利| 在线看一区二区 | 亚洲黄色成人网 | 国产精品色视频 | 美女国产网站 | 日韩国产欧美一区二区三区 | 亚洲综合激情网 | 国产免费激情视频 | 好吊色视频在线观看 | www.夜夜 | 一级片特黄 | 日韩毛片网站 | 五月婷婷伊人网 | 国产精品乱码一区二区视频 | 亚洲视频在线观看一区 | 欧美日韩一区二区三区在线 | 人人看人人干 | 色吧综合| 中国一级特黄毛片 | 天天国产视频 | 久久国产精品无码网站 | 国产精品亚洲天堂 | 一区二区三区四区五区视频 | 天天干天天透 |